References
- Fowler VG, Jr, Miro JM, Hoen B, Cabell CH, Abrutyn E, Rubinstein E. Staphylococcus aureus endocarditis: a consequence of medical progress. JAMA 2005; 293: 3012–21
- Baddour LM, Wilson WR, Bayer AS, Fowler VG, Jr, Bolger AF, Levison ME, et al. Infective endocarditis: diagnosis, antimicrobial therapy, and management of complications: a statement for healthcare professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American Heart Association: endorsed by the Infectious Diseases Society of America. Circulation 2005; 111: 394–434
- Westling K, Aufwerber E, Ekdahl C, Friman G, Gårdlund B, Julander I, et al. Swedish guidelines for diagnosis and treatment of infective endocarditis. Scand J Infect Dis 2007; 39: 929–46
- Falagas ME, Matthaiou DK, Bliziotis IA. The role of aminoglycosides in combination with a beta-lactam for the treatment of bacterial endocarditis: a meta-analysis of comparative trials. J Antimicrob Chemother 2006; 57: 639–47
- McDonald JR, Olaison L, Anderson DJ, Hoen B, Miro JM, Eykyn S, et al. Enterococcal endocarditis: 107 cases from the international collaboration on endocarditis merged database. Am J Med 2005; 118: 759–66
- Mainardi JL, Gutmann L, Acar JF, Goldstein FW. Synergistic effect of amoxicillin and cefotaxime against Enterococcus faecalis. Antimicrob Agents Chemother 1995; 39: 1984–7
- Gavalda J, Torres C, Tenorio C, López P, Zaragoza M, Capdevila JA, et al. Efficacy of ampicillin plus ceftriaxone in treatment of experimental endocarditis due to Enterococcus faecalis strains highly resistant to aminoglycosides. Antimicrob Agents Chemother 1999; 43: 639–46
- Gavalda J, Onrubia PL, Gómez MT, Gomis X, Ramirez JL, Len O, et al. Efficacy of ampicillin combined with ceftriaxone and gentamicin in the treatment of experimental endocarditis due to Enterococcus faecalis with no high-level resistance to aminoglycosides. J Antimicrob Chemother 2003; 52: 514–7
- Gavalda J, Len O, Miro JM, Muñoz P, Montejo M, Alarcon A, et al. Brief communication: treatment of Enterococcus faecalis endocarditis with ampicillin plus ceftriaxone. Ann Intern Med 2007; 146: 574–9
- Clinical and Laboratory Standards Institute (CLSI). Performance standards for antimicrobial susceptibility testing, 18th informational supplement. M100-S18. Vol. 28 No. 1. Clinical and Laboratory Standards Institute, Wayne, PA. 2008.
- Eliopoulos G, Moellering R. Antimicrobial combinations. Antibiotics in laboratory medicine4th edn, V Lorian. Williams & Wilkins, Baltimore 1996; 330–96
- Olaison L, Schadewitz K. Enterococcal endocarditis in Sweden, 1995–1999: can shorter therapy with aminoglycosides be used?. Clin Infect Dis 2002; 34: 159–66
- Patel IH, Chen S, Parsonnet M, Hackman MR, Brooks MA, Konikoff J, Kaplan SA. Pharmacokinetics of ceftriaxone in humans. Antimicrob Agents Chemother 1981; 20: 634–41